Program-Level Neoadjuvant Chemotherapy Use and 10-Year Survival in Advanced Ovarian Cancer.

Powers AER, Davis G, Jenkins D, Youssef A, Manning W, Wright JD, Keating NL, Bregar A, Rauh-Hain A, Melamed A

Open source

DOI
10.1001/jamanetworkopen.2026.34330
Published
2026 Sep 1
Container
JAMA network open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2026.34330,
  title = {Program-Level Neoadjuvant Chemotherapy Use and 10-Year Survival in Advanced Ovarian Cancer.},
  author = {Powers AER and Davis G and Jenkins D and Youssef A and Manning W and Wright JD and Keating NL and Bregar A and Rauh-Hain A and Melamed A},
  year = {2026},
  journal = {JAMA network open},
  doi = {10.1001/jamanetworkopen.2026.34330},
  url = {https://doi.org/10.1001/jamanetworkopen.2026.34330}
}

RIS

TY  - JOUR
TI  - Program-Level Neoadjuvant Chemotherapy Use and 10-Year Survival in Advanced Ovarian Cancer.
AU  - Powers AER
AU  - Davis G
AU  - Jenkins D
AU  - Youssef A
AU  - Manning W
AU  - Wright JD
AU  - Keating NL
AU  - Bregar A
AU  - Rauh-Hain A
AU  - Melamed A
PY  - 2026
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2026.34330
UR  - https://doi.org/10.1001/jamanetworkopen.2026.34330
ER  - 

APA

AER, P., G, D., D, J., A, Y., W, M., JD, W., NL, K., A, B., A, R., & A, M. (2026). Program-Level Neoadjuvant Chemotherapy Use and 10-Year Survival in Advanced Ovarian Cancer.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2026.34330

Source records